clinical trials for semaglutide AD/PD 2026: Novo Nordisk's fails to demonstrate any benefit early Alzheimer's Semaglutide 2.4 mg for the

At $16, Hims & Hers Health stock is cheap on sales metrics, but upside is capped pending regulatory clarity and proof of profit pool rebuild

PlexusDx explains the safety profile, potential absorption concerns, and how to optimize both medications for your health goals

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

PlexusDx provides compounded semaglutide injections starting at $149/month with full guidance for safe, effective self-administration

Two 131-patient cohorts with balanced baseline characteristics were formed by propensity score matching

Teva launches first generic GLP-1 drug in U.S., pricing liraglutide at $469.60 for two-pack, $704.40 for three-pack